Add BrightSurf on Google Email

Science News for October 11, 2001


Fresh hopes for treatment of malaria in Africa

Researchers have found a new antimalarial drug combination to be effective in treating falciparum malaria, the most severe form of the disease. In a study conducted in Tanzania, 93% of children were cleared of parasites after treatment with chlorproguanil-dapsone, compared to just 39% on standard pyrimethamine-sulfadoxine.

SourceThe Lancet_DELETED·JournalThe Lancet·DateOct 11, 2001

How a 'bad' gene may be good for you

Research suggests that the FVL mutation may have advantages for fetal implantation, resulting in higher success rates for fertility treatments. Women with the mutation experience improved receptivity to fertilized eggs, leading to increased pregnancy rates.

SourceThe Lancet_DELETED·JournalThe Lancet·DateOct 11, 2001

Mental math dependant on language

Bilinguals prefer their first taught language for mental arithmetic activities due to skills acquired, according to Texas A&M University research. This finding has significant educational implications, particularly in areas with high concentrations of bilingual populations.

SourceTexas A&M University·JournalRevista Española de Lingüística Aplicada/Spanish Journal of Applied Linguistics·DateOct 11, 2001

Best management for obstructed labour

Women who underwent vaginal instrumental delivery had a lower risk of serious bleeding and trauma compared to those who received caesarean section. The study supports the use of safe vaginal instrumental delivery for managing obstructed labour, especially in cases without clear evidence of disproportion.

SourceThe Lancet_DELETED·JournalThe Lancet·DateOct 11, 2001

New chemotherapy regimen produces long-term, disease-free survival in patients with uncommon, aggressive types of lymphoma, leukemia

Researchers found that brief cycles of high-dose chemotherapy produced long-term disease-free survival in more than half of adults treated for Burkitt's small non-cleaved lymphoma and leukemia. The regimen achieved an 80% complete response rate, with 52% of patients remaining in continuous remission after five years.

SourceAmerican Society of Clinical Oncology·JournalJournal of Clinical Oncology·DateOct 11, 2001

Opitcal coherent and ultrafast science

The National Science Foundation has established FOCUS, a Physics Frontier Center at the University of Michigan, to advance coherent control in quantum, ultrafast, and high-field physics. The center will focus on three major research components: High Field Control, Ultrafast Control, and Quantum Control.

Rotavirus vaccine found not guilty

A recent study found that Rotashield may trigger intussusception events in susceptible infants, but these risks are compensated for by a lower risk of intussusception later in infancy. The study analyzed hospital admissions of infants with intussusception in ten US states during the period when Rotashield was in use.

SourceThe Lancet_DELETED·JournalThe Lancet·DateOct 11, 2001

Women faculty in science and engineering

The University of Michigan has received a five-year, $3.7 million award from the National Science Foundation to improve opportunities for tenure-track women faculty in science and engineering fields. The project aims to address the slow increase in women faculty numbers over the past decade.